CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
Clinical trial NCT03285412 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03285412
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2026-04-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.